{"id":"https://openalex.org/W2150052456","doi":"https://doi.org/10.1158/1541-7786.mcr-07-0161","title":"Cyclin-Dependent Kinase Inhibitors Sensitize Tumor Cells to Nutlin-Induced Apoptosis: a Potent Drug Combination","display_name":"Cyclin-Dependent Kinase Inhibitors Sensitize Tumor Cells to Nutlin-Induced Apoptosis: a Potent Drug Combination","alternate_titles":[],"publication_year":2007,"publication_date":"2007-11-01","ids":{"openalex":"https://openalex.org/W2150052456","doi":"https://doi.org/10.1158/1541-7786.mcr-07-0161","mag":"2150052456","pmid":"https://pubmed.ncbi.nlm.nih.gov/18025259"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.mcr-07-0161","doi":"https://doi.org/10.1158/1541-7786.mcr-07-0161","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1541-7786.mcr-07-0161","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2150052456"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010315182","display_name":"Chit Fang Cheok","orcid":"https://orcid.org/0000-0001-8242-3995","observed_orcids":["https://orcid.org/0000-0001-8242-3995"]},"institutions":[{"id":"https://openalex.org/I75573869","display_name":"Institute of Molecular and Cell Biology","ror":"https://ror.org/04xpsrn94","country_code":"SG","type":"facility","lineage":["https://openalex.org/I115228651","https://openalex.org/I2801752549","https://openalex.org/I75573869"]}],"countries":["SG"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chit Fang Cheok","raw_affiliation_strings":["Institute of Molecular and Cell Biology, Proteos, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Molecular and Cell Biology, Proteos, Singapore","institution_ids":["https://openalex.org/I75573869"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036928216","display_name":"Anwesha Dey","orcid":"https://orcid.org/0000-0001-5688-5942","observed_orcids":["https://orcid.org/0000-0001-5688-5942"]},"institutions":[{"id":"https://openalex.org/I75573869","display_name":"Institute of Molecular and Cell Biology","ror":"https://ror.org/04xpsrn94","country_code":"SG","type":"facility","lineage":["https://openalex.org/I115228651","https://openalex.org/I2801752549","https://openalex.org/I75573869"]}],"countries":["SG"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anwesha Dey","raw_affiliation_strings":["Institute of Molecular and Cell Biology, Proteos, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Molecular and Cell Biology, Proteos, Singapore","institution_ids":["https://openalex.org/I75573869"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019407635","display_name":"David Philip Lane","orcid":"https://orcid.org/0000-0003-0551-3545","observed_orcids":["https://orcid.org/0000-0003-0551-3545"]},"institutions":[{"id":"https://openalex.org/I75573869","display_name":"Institute of Molecular and Cell Biology","ror":"https://ror.org/04xpsrn94","country_code":"SG","type":"facility","lineage":["https://openalex.org/I115228651","https://openalex.org/I2801752549","https://openalex.org/I75573869"]}],"countries":["SG"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David P. Lane","raw_affiliation_strings":["Institute of Molecular and Cell Biology, Proteos, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Molecular and Cell Biology, Proteos, Singapore","institution_ids":["https://openalex.org/I75573869"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I75573869"],"apc_list":null,"apc_paid":null,"fwci":4.9397,"has_fulltext":false,"cited_by_count":74,"citation_normalized_percentile":{"value":0.95728865,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"5","issue":"11","first_page":"1133","last_page":"1145"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nutlin-3a","display_name":"Nutlin-3a","score":0.9670000076293945},{"id":"https://openalex.org/keywords/mdm2-inhibitors","display_name":"MDM2 inhibitors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/p53-activation","display_name":"p53 activation","score":0.9570000171661377},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6240000128746033},{"id":"https://openalex.org/keywords/roscovitine","display_name":"roscovitine","score":0.9580000042915344},{"id":"https://openalex.org/keywords/drb","display_name":"DRB","score":0.9509999752044678},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7599999904632568},{"id":"https://openalex.org/keywords/puma","display_name":"PUMA","score":0.765999972820282},{"id":"https://openalex.org/keywords/pig3","display_name":"PIG3","score":0.9449999928474426},{"id":"https://openalex.org/keywords/wild-type-p53","display_name":"wild-type p53","score":0.7039999961853027},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8009999990463257},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.972000002861023},{"id":"https://openalex.org/keywords/breast-adenocarcinoma","display_name":"breast adenocarcinoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9259999990463257}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6119768023490906},{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.6105028986930847},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6041138172149658},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5981792211532593},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4851406514644623},{"id":"https://openalex.org/C2778298596","wikidata":"https://www.wikidata.org/wiki/Q17143494","display_name":"CDK inhibitor","level":5,"score":0.4715706706047058},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44646409153938293},{"id":"https://openalex.org/C2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","level":3,"score":0.44286826252937317},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.44204461574554443},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.43334415555000305},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3846285939216614},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33008724451065063},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32664787769317627},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.22026118636131287},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.13718181848526},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10846829414367676},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077546","descriptor_name":"Roscovitine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018844","descriptor_name":"Cyclin-Dependent Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047908","descriptor_name":"Intracellular Signaling Peptides and Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051017","descriptor_name":"Apoptosis Regulatory Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051736","descriptor_name":"Proto-Oncogene Proteins c-mdm2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051736","descriptor_name":"Proto-Oncogene Proteins c-mdm2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1541-7786.mcr-07-0161","doi":"https://doi.org/10.1158/1541-7786.mcr-07-0161","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1541-7786.mcr-07-0161","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},{"id":"pmid:18025259","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18025259","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer research : MCR","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W1484532115","https://openalex.org/W1532268646","https://openalex.org/W1592483428","https://openalex.org/W1611726375","https://openalex.org/W1650797637","https://openalex.org/W1677175288","https://openalex.org/W1973821009","https://openalex.org/W1975004085","https://openalex.org/W1979403925","https://openalex.org/W1986250681","https://openalex.org/W1989581593","https://openalex.org/W1991985869","https://openalex.org/W1996632098","https://openalex.org/W1998359028","https://openalex.org/W2003168089","https://openalex.org/W2003236156","https://openalex.org/W2004273407","https://openalex.org/W2007926623","https://openalex.org/W2013499751","https://openalex.org/W2029350002","https://openalex.org/W2039771541","https://openalex.org/W2044079387","https://openalex.org/W2049133549","https://openalex.org/W2063669247","https://openalex.org/W2071236164","https://openalex.org/W2073576377","https://openalex.org/W2077165680","https://openalex.org/W2077945404","https://openalex.org/W2081567150","https://openalex.org/W2082979850","https://openalex.org/W2097933346","https://openalex.org/W2099907467","https://openalex.org/W2100494757","https://openalex.org/W2103231366","https://openalex.org/W2105155498","https://openalex.org/W2108638396","https://openalex.org/W2111186987","https://openalex.org/W2111888491","https://openalex.org/W2113724972","https://openalex.org/W2114103020","https://openalex.org/W2115147179","https://openalex.org/W2124380422","https://openalex.org/W2126390187","https://openalex.org/W2127423053","https://openalex.org/W2139223131","https://openalex.org/W2141762576","https://openalex.org/W2142496621","https://openalex.org/W2147347134","https://openalex.org/W2148330261","https://openalex.org/W2154799239","https://openalex.org/W2155640249","https://openalex.org/W2158669039","https://openalex.org/W2159099751","https://openalex.org/W2160178368","https://openalex.org/W2160854466","https://openalex.org/W2161379087","https://openalex.org/W2169013758","https://openalex.org/W2171407623","https://openalex.org/W2312795792","https://openalex.org/W2319273072","https://openalex.org/W4212962560"],"related_works":["https://openalex.org/W2093638163","https://openalex.org/W65729443","https://openalex.org/W4318620485","https://openalex.org/W2016586007","https://openalex.org/W1980581519","https://openalex.org/W2108525940","https://openalex.org/W2090717939","https://openalex.org/W2609083662","https://openalex.org/W2795510630","https://openalex.org/W2269849734"],"abstract_inverted_index":{"Current":[0],"chemotherapy":[1],"focuses":[2],"on":[3,118,126,200,217],"the":[4,50,85,90,108,113,119,150,209,229,240],"use":[5,241],"of":[6,22,29,53,65,77,92,107,121,133,138,152,158,169,178,198,227,242],"genotoxic":[7,206],"drugs":[8,215],"that":[9,74,112,212],"may":[10,233],"induce":[11,196,205,221],"general":[12],"DNA":[13,224],"damage":[14],"in":[15,24,42,58,89,99,175,208,248],"cancer":[16],"cells":[17,180],"but":[18],"also":[19],"high":[20],"levels":[21],"toxicity":[23],"normal":[25],"tissues.":[26],"Nongenotoxic":[27],"activation":[28,226],"p53":[30,93,153,201],"by":[31],"targeting":[32],"specific":[33],"molecular":[34],"pathways":[35],"therefore":[36],"provides":[37],"an":[38],"attractive":[39],"therapeutic":[40,237],"strategy":[41],"cancers":[43],"with":[44,60,84,149],"wild-type":[45],"p53.":[46],"Here,":[47],"we":[48],"explored":[49],"antitumor":[51],"potential":[52],"cyclin-dependent":[54],"kinase":[55],"(CDK)":[56],"inhibitors":[57,79,244],"combination":[59,109,115,172,193],"a":[61,100,129,176,235],"small":[62],"molecule":[63],"inhibitor":[64],"p53-murine":[66],"double":[67],"minute":[68],"2":[69],"(MDM2)":[70],"interaction.":[71],"We":[72],"show":[73],"low":[75],"doses":[76],"CDK":[78,243],"roscovitine":[80],"and":[81,95,102,124,155,162,166,187,202,245],"DRB":[82],"synergize":[83],"MDM2":[86,246],"antagonist":[87],"nutlin-3a":[88],"induction":[91,157],"activity":[94],"promote":[96],"p53-dependent":[97],"apoptosis":[98,139,222],"dose-":[101],"time-dependent":[103],"manner.":[104],"Statistical":[105],"measurement":[106],"effects":[110,168],"shows":[111],"drug":[114,146,171,192,250],"is":[116],"additive":[117],"reduction":[120],"cell":[122],"viability":[123],"synergistic":[125],"inducing":[127],"apoptosis,":[128],"critical":[130],"end":[131],"point":[132],"cytotoxic":[134,167,214],"drugs.":[135],"The":[136,164],"degree":[137],"observed":[140],"24":[141],"to":[142,220],"48":[143],"h":[144],"after":[145],"treatment":[147],"correlated":[148],"accumulation":[151],"protein":[154],"concomitant":[156],"proapoptotic":[159],"proteins":[160],"Puma":[161],"PIG3.":[163],"antiproliferative":[165],"this":[170,191],"are":[173],"validated":[174],"range":[177],"tumor-derived":[179],"including":[181],"melanoma,":[182],"colon":[183],"carcinoma,":[184],"breast":[185],"adenocarcinoma,":[186],"hepatocarcinoma":[188],"cells.":[189],"Furthermore,":[190],"does":[194,203],"not":[195,204],"phosphorylation":[197],"Ser(15)":[199],"stress":[207],"cell.":[210],"Given":[211],"many":[213],"rely":[216],"their":[218],"ability":[219],"via":[223],"damage-mediated":[225],"p53,":[228],"data":[230],"presented":[231],"here":[232],"provide":[234],"new":[236],"approach":[238],"for":[239],"antagonists":[247],"combinatorial":[249],"therapy.":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2150052456","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
